Soquinolol
From Wikipedia, the free encyclopedia
This article needs more links to other articles to help integrate it into the encyclopedia. (September 2015) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-isoquinoline-2-carbaldehyde
|
|
Identifiers | |
61563-18-6 | |
3D model (Jmol) | Interactive image Interactive image |
ChemSpider | 62047 |
ECHA InfoCard | 100.057.113 |
PubChem | 68811 |
|
|
|
|
Properties | |
C17H26N2O3 | |
Molar mass | 306.41 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Soquinolol is a beta adrenergic receptor antagonist.[1]
References[edit]
- ^ Gries, J; Unger, L; Einig, H; Friedrich, L; Hofmann, HP; Kreiskott, H; Lehmann, HD; Von Philipsborn, G; Wuppermann, D; Zimmermann, F (1988). "Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol". Arzneimittel-Forschung. 38 (9): 1271–9. PMID 2906243.
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |